Compare Stocks

LED Medical Diagnostics Inc. develops and markets diagnostic dental imaging products and software in North America. Its products include Velscope Vx system, a device for the enhanced visualization of oral mucosal abnormalities, such as oral cancer and premalignant dysplasia; VELscope Vx imaging adapter for fluorescence and white-light clinical imaging; Vx VELcaps to prevent patient cross contamination; Vx VELsheaths, a single use plastic sheath to prevent patient cross contamination; and VELscope and Vx Value Bundle, a portable handheld device used to conduct oral tissue examinations. The company also provides XrayVision DICOM Capture View (DCV), a dental imaging suite to capture, storage, retrieve, and view images across an entire organization; XV4 Mobile for patient follow-up and emergency use in the operating room, remote or mobile clinic, or at home; XVWeb, a Web application that allows an organization to view their images from various Web-enabled devices; and XrayVision, an open-architecture digital image management program. In addition, it offers XV Sync that enables automatic synchronization of various databases for a dental practice; DataGrabber, which allows a customer to bridge patient information from various patient management software packages to a customer's digital imaging software; DCV Data Manager, a picture archive and communication system server application; and XVLite, an open architecture digital dental x-ray software package for capturing, enhancing, and displaying dental images. Further, the company provides data mapping and database conversion services; intraoral digital radiographic sensors under the Tuxedo name; intraoral cameras; and 3D imagining hardware products under the RAYSCAN name. It serves dentists and oral health specialists. LED Medical Diagnostics Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada.

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity of chemotherapy treatments for cancer, and Covid-19 related heart issues. The company was incorporated in 2005 and is headquartered in Toronto, Canada.